BMO Capital Maintains Market Perform on Neighbourly Pharmacy, Lowers Price Target to C$21
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst Peter Sklar has maintained a 'Market Perform' rating on Neighbourly Pharmacy (TSX:NBLY) and lowered the price target from C$23 to C$21.
August 04, 2023 | 11:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BMO Capital has maintained a 'Market Perform' rating on Neighbourly Pharmacy and lowered the price target from C$23 to C$21.
The lowering of the price target by BMO Capital from C$23 to C$21 indicates a less optimistic outlook for the company's stock in the short term. This could potentially lead to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100